Board of Directors


Jan-Olof Lundin

Non-executive Chairman


Jan-Olof brings international business experience on management and CEO level, mainly from the chemical and biotech industries VBB AB, EKA Chemicals AB, Berol Verkstadskemi AB (part of the Akzo Nobel group) and, most recently, from Diffchamb AB (publ.).

Carolyn Rand

Chief Executive Officer

Emma joined Isogenica as Chief Executive Officer in September 2018. She is passionate about technologies that can accelerate drug discovery and development, and experienced in leading highly innovative, scientific companies from start-up through multiple product launches, to rapidly growing sustainable businesses.

Non-executive Director


Renny is currently interim CEO of the Eastern Academic Health Sciences Network (AHSN) based at Addenbrooke’s Hospital in Cambridge.  Prior to that he founded the South West AHSN across Devon Somerset and Cornwall working in partnership with the academic

Göran Forsberg

Non-executive Director


Göran is currently Chief Executive Officer at Cantargia AB, Lund, Sweden. Cantargia is a biotech company developing monoclonal antibodies for the treatment of cancer.

Niclas Eriksson

Non-executive Director


Niclas has been in the investment business since 1992, through Vasastaden Holding AB and Kungsstaden Fastighet AB and positions at the broker firm Consensus as well as the financial services company Capinova.